Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP)’s traded shares stood at 1.22 million during the last session, with the company’s beta value hitting 2.46. At the close of trading, the stock’s price was $0.99, to imply a decrease of -4.17% or -$0.04 in intraday trading. The ADAP share’s 52-week high remains $2.05, putting it -107.07% down since that peak but still an impressive 57.58% since price per share fell to its 52-week low of $0.42. The company has a valuation of $224.22M, with an average of 1.94 million shares over the past 3 months.
Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) trade information
After registering a -4.17% downside in the last session, Adaptimmune Therapeutics Plc ADR (ADAP) has traded red over the past five days. The stock hit a weekly high of 1.3400, dropping -4.17% in its intraday price action. The 5-day price performance for the stock is -22.28%, and -32.86% over 30 days. With these gigs, the year-to-date price performance is 24.46%.
Adaptimmune Therapeutics Plc ADR (ADAP) estimates and forecasts
Looking at statistics comparing Adaptimmune Therapeutics Plc ADR share performance against respective industry, we note that the company has outperformed competitors. Adaptimmune Therapeutics Plc ADR (ADAP) shares are 48.42% up over the last 6 months, with its year-to-date growth rate higher than industry average at 22.22% against 12.80%.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 10.30% for the past 5-year period. While 2024 is set for a -359.00% return in earnings, projections for the next 5 years are at 1.00% annually.
ADAP Dividends
Adaptimmune Therapeutics Plc ADR has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Adaptimmune Therapeutics Plc ADR has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
